Ann Lab Med.  2024 Sep;44(5):459-462. 10.3343/alm.2024.0036.

Association Between Plasma Anti-Factor Xa Concentrations and Large Artery Occlusion in Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants for Non-valvular Atrial Fibrillation

• Kim DH
• Kwak BC
• Yoon BA
• Cha JK
• Park JS
• Kwak MS
• Woo KS
• Han JY

• KMID: 2559154
• DOI: http://doi.org/10.3343/alm.2024.0036

Reference

References

1. Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, et al. 2014; Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry. Int J Stroke. 9:514–8. DOI: 10.1111/ijs.12199. PMID: 24256115.

2. McGrath ER, Kapral MK, Fang J, Eikelboom JW, Conghaile Aó, Canavan M, et al. 2013; Association of atrial fibrillation with mortality and disability after ischemic stroke. Neurology. 81:825–32. DOI: 10.1212/WNL.0b013e3182a2cc15. PMID: 23902702.

3. Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. 2021; 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 23:1612–76. DOI: 10.1093/europace/euab065. PMID: 33895845.

4. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2021; 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 42:373–498. DOI: 10.1093/eurheartj/ehaa612. PMID: 32860505.

5. Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, et al. 2022; 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost. 122:20–47. DOI: 10.1055/s-0041-1739411. PMID: 34773920. PMCID: PMC8763451.

6. Macha K, Marsch A, Siedler G, Breuer L, Strasser EF, Engelhorn T, et al. 2019; Cerebral ischemia in patients on direct oral anticoagulants. Stroke. 50:873–9. DOI: 10.1161/STROKEAHA.118.023877. PMID: 30852963.

7. Siller T, Chandratheva A, Bucke P, Werring DJ, Seiffge D. 2021; Acute stroke treatment in an anticoagulant patient: when is thrombolysis as option? Curr Treat Options Neurol. 23:41. DOI: 10.1007/s11940-021-00695-z.

8. Rizos T, Meid AD, Huppertz A, Dumschat C, Purrucker J, Foerster KI, et al. 2022; Low exposure to direct oral anticoagulants is associated with ischemic stroke and its severity. J Stroke. 24:88–97. DOI: 10.5853/jos.2020.04952. PMID: 35135063. PMCID: PMC8829480. PMID: 86edab435408461b9a19d53330cd6373.

9. Chao TF, Chen SA, Ruff CT, Hamershock RA, Mercuri MF, Antman EM, et al. 2019; Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 40:1518–27. DOI: 10.1093/eurheartj/ehy807. PMID: 30590425.